Download the app

DOWNLOAD NOW

watsons online, download the app
  • google-play.png
  • app-store.png
  • app-gallery.png
Our Stores Trending Now
Stores Services
0
MY Bag
Home/Health and RX/Prescription/Others/

Calcitriol 25mcg 1 Capsule [Prescription Required]

Calcitriol 25mcg 1 Capsule [Prescription Required]
Subscription
See How Subscription works
One Time Purchase
Subscribe – delivers every 1 month(s); Total 3 deliveries
One upfront payment
Subscribe – delivers every 1 month(s); Total 6 deliveries
One upfront payment
24.00
Notify Me
delivery method
Home Delivery
Click & Collect
Product code
50005533
  • Product Details
  • About This Shop
  • Promotion
  • Payment & Delivery
Product Details
Description

TREATMENT AND PREVENTION OF VITAMIN D DEFICIENCY STATES AND HYPOCALCAEMIA IN DISORDERS SUCH AS HYPOPARATHYROIDISM AND SECONDARY HYPOPARATHYROIDISM. IT IS IN THE TREATMENT OF OSTEOPOROSIS.

Place of Origin

VIETNAM

Product Usage

THE USUAL INITIAL ADULT ORAL DOSE IS 0.25mcg (1 CAPSULE) DAILY ON ALTERNATE DAYS ARE GIVEN, INCREASED IF NECESSARY, IN STEPS OF 0.25mcg (1 CAPSULE) AT INTERVALS OF 2 TO 4 WEEKS, TO USUAL DOSE OF 0.25mcg (2 CAPSULE) TO 1mcg (4 CASULES DAILY). FOR MODERATE TO SEVERE SECONDARY HYPERRATHYROIDISM IN DIALYSIS PATIENTS, INITIAL DOSE OF 0.25mcg (2 CAPSULE) TO 4mcg (8 CAPSULE) HAVE BEEN GIVEN THREE TIMES A WEEK, INCREASED IF NECESSARY IN STEPS OF 0.25mcg (1 CAPSULE) TO 1mcg (4 CAPSULE) AT INTERVALS OF 2-4 WEEKS A MAXIMUM OF 8mcg (16 CAPSULES) GIVEN THREE TIMES A WEEK. IN ESTABLISHED POSTMENOPOSAL OSTEOPOROSIS, A DOSE OF 0.25mcg (1 CAPSULE) TWICE DAILY RECOMMENDED. WHEN VITAMIN D SUBTANCES ARE GIVEN IN PHARMACOLOGICAL DOSES, DOSAGE MUST BE INDIVIDUALIZED FOR EACH PATIENT, AND SHOULD BE BASED ON REGULAR MONITORING OF PLASMA-CONCENTRATIONS (INITIALLY ONCE OR TWICE WEEKLY), TO OPTIMIZE CLINICAL RESPONSE AND AVOID HYPERCALCAEMIA.

Ingredients

CALCITRIOL

Warnings

1. ALL KINDS OF DESEASES RELATED TO HYPERCALCEMIA. 2. PATIENTS WITH HISTORY OF HYPERSENSITIVITY TO THIS DRUG OR ANY COMPONENTS OF THIS DRUG. 3. PATIENTS WITH EVIDENCE OF VITAMIN D TOXICITY.

HIDE